These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 27916432)

  • 1. The international generalisability of evidence for health policy: A cross country comparison of medication adherence following policy change.
    Sinnott SJ; Whelton H; Franklin JM; Polinski JM
    Health Policy; 2017 Jan; 121(1):27-34. PubMed ID: 27916432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copayments for prescription medicines on a public health insurance scheme in Ireland.
    Sinnott SJ; Normand C; Byrne S; Woods N; Whelton H
    Pharmacoepidemiol Drug Saf; 2016 Jun; 25(6):695-704. PubMed ID: 26696242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unintended consequences of a Medicaid prescription copayment policy.
    Lieberman DA; Polinski JM; Choudhry NK; Avorn J; Fischer MA
    Med Care; 2014 May; 52(5):422-7. PubMed ID: 24686394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing time costs and copayments for prescription drugs: an analysis of policy changes in a complex environment.
    Domino ME; Martin BC; Wiley-Exley E; Richards S; Henson A; Carey TS; Sleath B
    Health Serv Res; 2011 Jun; 46(3):900-19. PubMed ID: 21306363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Medicaid prescription copayments on use of antipsychotics and other medications in patients with schizophrenia.
    Doshi JA; Li P; Desai S; Marcus SC
    J Med Econ; 2017 Dec; 20(12):1252-1260. PubMed ID: 28792299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Medicaid Policy Changes on Medication Adherence: Differences by Baseline Adherence.
    Amin K; Farley JF; Maciejewski ML; Domino ME
    J Manag Care Spec Pharm; 2017 Mar; 23(3):337-345. PubMed ID: 28230447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic Health Outcomes and Prescription Drug Copayments in Medicaid.
    Kostova D; Fox J
    Med Care; 2017 May; 55(5):520-527. PubMed ID: 28234755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of a Medicaid copayment policy on prescription drug and health services utilization in a fee-for-service Medicaid population.
    Hartung DM; Carlson MJ; Kraemer DF; Haxby DG; Ketchum KL; Greenlick MR
    Med Care; 2008 Jun; 46(6):565-72. PubMed ID: 18520310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Payment restrictions for prescription drugs under Medicaid. Effects on therapy, cost, and equity.
    Soumerai SB; Avorn J; Ross-Degnan D; Gortmaker S
    N Engl J Med; 1987 Aug; 317(9):550-6. PubMed ID: 3302713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing pharmaceutical copayments: impact on asthma medication utilization and outcomes.
    Campbell JD; Allen-Ramey F; Sajjan SG; Maiese EM; Sullivan SD
    Am J Manag Care; 2011 Oct; 17(10):703-10. PubMed ID: 22106463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of a transition to more restrictive drug formulary on therapy discontinuation and medication adherence.
    Shirneshan E; Kyrychenko P; Matlin OS; Avila JP; Brennan TA; Shrank WH
    J Clin Pharm Ther; 2016 Feb; 41(1):64-9. PubMed ID: 26778812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of copayment policies on initial medication non-adherence according to income: a population-based study.
    Aznar-Lou I; Pottegård A; Fernández A; Peñarrubia-María MT; Serrano-Blanco A; Sabés-Figuera R; Gil-Girbau M; Fajó-Pascual M; Moreno-Peral P; Rubio-Valera M
    BMJ Qual Saf; 2018 Nov; 27(11):878-891. PubMed ID: 29545326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential bias in medication adherence studies of prevalent users.
    Maciejewski ML; Bryson CL; Wang V; Perkins M; Liu CF
    Health Serv Res; 2013 Aug; 48(4):1468-86. PubMed ID: 23402554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescription co-pay reduction program for diabetic employees.
    Nair KV; Miller K; Park J; Allen RR; Saseen JJ; Biddle V
    Popul Health Manag; 2010 Oct; 13(5):235-45. PubMed ID: 20879904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-related prescription nonadherence in the United States and Canada: a system-level comparison using the 2007 International Health Policy Survey in Seven Countries.
    Kennedy J; Morgan S
    Clin Ther; 2009 Jan; 31(1):213-9. PubMed ID: 19243719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of copayments on drug use in the presence of annual payment limits.
    Kephart G; Skedgel C; Sketris I; Grootendorst P; Hoar J
    Am J Manag Care; 2007 Jun; 13(6 Pt 2):328-34. PubMed ID: 17567233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a medication copayment increase in veterans with schizophrenia.
    Zeber JE; Grazier KL; Valenstein M; Blow FC; Lantz PM
    Am J Manag Care; 2007 Jun; 13(6 Pt 2):335-46. PubMed ID: 17567234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Copayments for medications after June 30, 2010. Final rule.
    Department of Veterans Affairs
    Fed Regist; 2011 Feb; 76(35):9646-8. PubMed ID: 21351679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Who bears the burden of Medicaid drug copayment policies?
    Stuart B; Zacker C
    Health Aff (Millwood); 1999; 18(2):201-12. PubMed ID: 10091449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of patient sex and gender on medication use, adherence, and prescribing alignment with guidelines.
    Manteuffel M; Williams S; Chen W; Verbrugge RR; Pittman DG; Steinkellner A
    J Womens Health (Larchmt); 2014 Feb; 23(2):112-9. PubMed ID: 24206025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.